Vistin Pharma ASA Cash Flow-to-Debt Ratio
Vistin Pharma ASA cash flow-to-debt ratio. Vistin Pharma ASA (VISTN) has a Cash Flow-to-Debt Ratio of -0.04x as of March 2026, meaning its operating cash flow of Nkr-3.67 Million could theoretically repay 0% of its total liabilities (Nkr103.25 Million) in one year. Check earnings quality score of Vistin Pharma ASA to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Vistin Pharma ASA (2016–2025)
Cash flow-to-debt ratio of Vistin Pharma ASA from 2016 to 2025. Historical debt coverage capacity for Vistin Pharma ASA across 10 annual periods. Check Vistin Pharma ASA (VISTN) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Vistin Pharma ASA Cash Flow-to-Debt Ratio by Year (2016–2025)
Vistin Pharma ASA cash flow-to-debt ratio by year from 2016 to 2025. Year-by-year debt coverage analysis for Vistin Pharma ASA. For the full cash flow conversion analysis, see VISTN cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (NOK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.71x | Nkr78.04 Million | Nkr110.62 Million | ▼ -50.7% |
| 2024 | 1.43x | Nkr107.86 Million | Nkr75.42 Million | ▲ +27.3% |
| 2023 | 1.12x | Nkr90.59 Million | Nkr80.63 Million | ▲ +1797.2% |
| 2022 | -0.07x | Nkr-8.87 Million | Nkr133.95 Million | ▼ -127.7% |
| 2021 | 0.24x | Nkr13.68 Million | Nkr57.26 Million | ▲ +108.1% |
| 2020 | -2.94x | Nkr-145.73 Million | Nkr49.51 Million | ▼ -1511.0% |
| 2019 | 0.21x | Nkr18.93 Million | Nkr90.77 Million | ▲ +179.9% |
| 2018 | -0.26x | Nkr-39.48 Million | Nkr151.21 Million | ▼ -406.4% |
| 2017 | 0.09x | Nkr9.51 Million | Nkr111.59 Million | ▼ -85.3% |
| 2016 | 0.58x | Nkr53.84 Million | Nkr92.91 Million | — |